NCT07068789 Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia
| NCT ID | NCT07068789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Chronic Limb Threatening Ischemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-25 |
| Primary Completion | 2025-08-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-25 with a primary completion date of 2025-08-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This interventional prospective study aims to assess the effectiveness of single vessel versus multiple vessel infrapopliteal angioplasty in patients with chronic threatening limb ischemia . The study compares limb salvage rates and clinical outcomes across two groups over a defined follow up period
Eligibility Criteria
Inclusion Criteria: 1. patients aged 40 years or older 2. patients with Rutherford category "4" and "5" 3. patients with angiographic evidence of infrapopliteal vessel occlusive disease - Exclusion Criteria: 1. patients who refuse to participate in the study 2. patients with isolated proximal arterial disease (e.g SFA or popliteal ) without infrapopliteal involvement 3. patients who develop acute thrombosis , flow limiting dissection or perforation in the infrapopliteal arteries during intervention -
Contact & Investigator
Mahmoud Abdelrahman hafez, Master's student
✉ mahmoud.abdelrahmaan@med.sohag.edu.eg📞 +0201060150246
Frequently Asked Questions
Who can join the NCT07068789 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Chronic Limb Threatening Ischemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07068789 currently recruiting?
Yes, NCT07068789 is actively recruiting participants. Contact the research team at mahmoud.abdelrahmaan@med.sohag.edu.eg for enrollment information.
Where is the NCT07068789 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07068789 clinical trial?
NCT07068789 is sponsored by Sohag University. The trial plans to enroll 40 participants.